Type 2 Diabetes

HealthFirst head-to-head trial compares tirzepatide and semaglutide – Results are in!

The study involved 751 adults with obesity but no type 2 diabetes. The participants were randomly assigned to take either tirzepatide or semaglutide.

Joshua Shavit